Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
- 1 January 1988
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 6 (1) , 147-153
- https://doi.org/10.1200/jco.1988.6.1.147
Abstract
All mesothelioma patients identified by a computer search of pathologic diagnoses at the Dana-Farber Cancer Institute (DFCI) between 1965 and 1985 were the subjects of this analysis. A total of 180 patients were identified, 136 with pleural and 37 with peritoneal mesothelioma. There were five pericardial and two testicular primaries. Of the two decades included in the study, later patients were significantly older, with a more advanced disease stage, and a lower performance status than those accrued early in the study. Factors at diagnosis associated with a significantly prolonged survival for all patients with mesothelioma included a 0 to 1 performance status, absence of chest pain, age less than 50 years, and epithelial histology. Factors at diagnosis associated with prolonged survival for the subset of patients with pleural mesothelioma included epithelial histology, 0 to 1 performance status, the absence of chest pain, an interval of greater than 6 months from onset of symptoms, and treatment with che...This publication has 5 references indexed in Scilit:
- RANDOMIZED TRIAL OF DOXORUBICIN VERSUS CYCLOPHOSPHAMIDE IN DIFFUSE MALIGNANT PLEURAL MESOTHELIOMA1985
- EARLY PERITONEAL MESOTHELIOMA: A TREATABLE MALIGNANCYThe Lancet, 1985
- Diffuse Malignant MesotheliomaAnnals of Internal Medicine, 1982
- Multimodality therapy for malignant mesothelioma based on a study of natural historyThe American Journal of Medicine, 1980
- The value of adriamycin in the treatment of diffuse malignant pleural mesotheliomaCancer, 1978